Physician profile
Evan Carlos
NPI 1063807477
$18,307.68
in general payments reported to CMS, 2019-2025
49 companies · $9,725 in 2025
The $9,725 reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,149 · 2022: $1,227 · 2023: $2,365 · 2024: $3,841 · 2025: $9,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,900 · Food and Beverage: $5,714 · Travel and Lodging: $267 · Education: $35.06 · Entertainment: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,900.00 |
| Food and Beverage | $5,714.01 |
| Travel and Lodging | $267.28 |
| Education | $35.06 |
| Entertainment | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $11,783.30 | 2023-2025 | |
| Histosonics, INC. | $1,160.04 | 2024 | |
| Sumitomo Pharma America, INC. | $451.66 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $429.80 | 2024 | Adstiladrin |
| Boston Scientific Corporation | $398.42 | 2021-2025 | Lithovue Elite, Lithovue |
| Janssen Biotech, INC. | $394.62 | 2021-2025 | Erleada |
| Teleflex LLC | $301.10 | 2021-2023 | Urolift |
| Rochester Medical Corporation | $276.92 | 2022 | |
| Urogen Pharma, INC. | $237.39 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $233.54 | 2021-2023 | |
| Calyxo, INC. | $229.68 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $229.32 | 2022-2025 | Botox |
| Astellas Pharma US INC | $171.18 | 2021-2023 | Myrbetriq |
| Accord Healthcare, INC. | $167.99 | 2024-2025 | |
| Bluewind Medical | $149.97 | 2024 | Revi |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Carlos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.